These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 16142283)

  • 1. Humoral immune response to recombinant viral NS3 protein in patients with hepatitis C.
    Gudim EA; Agapov II; Komolov IS; Tonevitskii AG
    Bull Exp Biol Med; 2005 Jan; 139(1):77-80. PubMed ID: 16142283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of monoclonal antibodies against hepatitis C virus nonstructural protein 3: different antigenic determinants from human B cells.
    Ou-Yang P; Chiang BL; Hwang LH; Chen YG; Yang PM; Chi WK; Chen PJ; Chen DS
    J Med Virol; 1999 Apr; 57(4):345-50. PubMed ID: 10089044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The combined application of nucleotide and amino acid sequences of NS3 hepatitis C virus protein, DNA encoding granulocyte macrophage colony-stimulating factor and inhibitor of regulatory T cells induces effective immune response against hepatitis C virus].
    Masalova OV; Lesnova EI; Shingarova LN; Tunitskaia VL; Ulanova TI; Burkov AN; Kushch AA
    Mol Biol (Mosk); 2012; 46(3):525-34. PubMed ID: 22888642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Impact of the heterogenicity of amino acid sequence on the immunoreactivity of an antigenic epitopic complex localized within amino acids 1192-1456 of protein NS3 protein of hepatitis C virus].
    Ulanova TI; Puzyrev VF; Burkov AN; Obriadina AP
    Vopr Virusol; 2006; 51(1):28-30. PubMed ID: 16515039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Truncated HCV-NS3 Protein for Potential Applications in Immunization and Diagnosis.
    Javadi F; Rahimi P; Modarressi MH; Bolhassani A; Ardestani MS; Sadat SM; Aghasadeghi MR
    Clin Lab; 2016 Jul; 62(7):1271-1278. PubMed ID: 28164628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diagnostic possibilities of an immunoenzyme test-system for determining the spectrum of antibodies to structural and nonstructural hepatitis C virus antigens].
    Pimenov VK; Afanas'ev AIu; Kolobov AA; Zubov SV; Dobrotina NA; Novikov VV
    Vopr Virusol; 2000; 45(6):44-7. PubMed ID: 11200648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prokaryotic Expression of Hepatitis C Virus-NS3 Protein and Preparation of a Monoclonal Antibody.
    Xi Y; Zhang Y; Fang J; Whittaker K; Luo S; Huang RP
    Monoclon Antib Immunodiagn Immunother; 2017 Dec; 36(6):251-258. PubMed ID: 29267148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human and murine antibody recognition is focused on the ATPase/helicase, but not the protease domain of the hepatitis C virus nonstructural 3 protein.
    Chen M; Sällberg M; Sönnerborg A; Jin L; Birkett A; Peterson D; Weiland O; Milich DR
    Hepatology; 1998 Jul; 28(1):219-24. PubMed ID: 9657115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antigenic heterogeneity of the NS3 proteins in hepatitis C virus genotypes 1 and 6.
    Qiao W; Xie P; Cai B; Li L
    Intervirology; 2011 Feb; 54(2):53-60. PubMed ID: 20829600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variation in antibody reactivity to the hepatitis C virus by comparative immunoscreening and enzyme immunoassay.
    Gish RG; Warmerdam MT; Zeldis JB; Keeffe EB; Nakazato P; Lim J; Cox K; Kuramoto IK; Fry KE; Yarbough PO
    Viral Immunol; 1993; 6(1):49-54. PubMed ID: 7682814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Use of synthetic peptides as additional antigens for detecting antibodies to hepatitis C virus].
    Semiletov IuA; Firsova TV; Kruglov IV; Alekseenkova TI; Petrakova NV; Kalinina TI; Shibnev VA
    Vopr Virusol; 1998; 43(3):107-9. PubMed ID: 9702806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antigenicities of Group I and II hepatitis C virus polypeptides--molecular basis of diagnosis.
    Tsukiyama-Kohara K; Yamaguchi K; Maki N; Ohta Y; Miki K; Mizokami M; Ohba K; Tanaka S; Hattori N; Nomoto A
    Virology; 1993 Feb; 192(2):430-7. PubMed ID: 7678473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of specific antibody assay for genotyping of hepatitis C virus.
    Tanaka T; Tsukiyama-Kohara K; Yamaguchi K; Yagi S; Tanaka S; Hasegawa A; Ohta Y; Hattori N; Kohara M
    Hepatology; 1994 Jun; 19(6):1347-53. PubMed ID: 7514558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel combined vaccine candidate containing epitopes of HCV NS3, core and E1 proteins induces multi-specific immune responses in BALB/c mice.
    Zeng R; Li G; Ling S; Zhang H; Yao Z; Xiu B; He F; Huang R; Wei L
    Antiviral Res; 2009 Oct; 84(1):23-30. PubMed ID: 19646486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recognition of synthetic oligopeptides from nonstructural proteins NS1 and NS3 of dengue-4 virus by sera from dengue virus-infected children.
    Garcia G; Vaughn DW; Del Angel RM
    Am J Trop Med Hyg; 1997 Apr; 56(4):466-70. PubMed ID: 9158059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of humoral antigenic determinants in the hepatitis C virus NS3 protein.
    Hwang LH; Yang PM; Lai MY; Chiang BL; Kao JH; Wang JT; Lee SY; Chian HM; Chi WK; Chu YD; Chen PJ; Chen DS
    J Infect Dis; 1996 Jul; 174(1):173-6. PubMed ID: 8655988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparative analysis of the immune response to DNA constructions encoding hepatitis C virus nonstructural proteins].
    Masalova OV; Lesnova EI; Ivanov AV; Pichugin AV; Permiakova KIu; Smirnova OA; Tynitskaia VL; Ulanova TI; Burkov AN; Kochetkov SN; Ataullakhanov RI; Kushch AA
    Vopr Virusol; 2013; 58(2):21-8. PubMed ID: 23785766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis C virus nonstructural 3 protein: recombinant NS3 protein of the Thai isolates as an antigen in a diagnostic assay.
    Kanistanon D; Wongprompitak P; Dharakul T; Songsivilai S
    Asian Pac J Allergy Immunol; 2002 Sep; 20(3):161-6. PubMed ID: 12587839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of mimotopes mimicking an immunodominant conformational epitope on the hepatitis C virus NS3 helicase.
    Jolivet-Reynaud C; Adida A; Michel S; Deléage G; Paranhos-Baccala G; Gonin V; Battail-Poirot N; Lacoux X; Rolland D
    J Med Virol; 2004 Mar; 72(3):385-95. PubMed ID: 14748062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Engineering of the hepatitis C virus helicase for enhanced seroreactivity.
    Marohnic CC; Birkenmeyer LG; Bogdan MF; Frias EC; Otis KS; Palafox MAP; McSherry TD; Gregory SD; Zhao C; Gutierrez RA; Prostko JC; Muerhoff AS
    J Virol Methods; 2019 Feb; 264():11-17. PubMed ID: 30381240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.